Preterm Delivery: Clinical Trials

9 trials for Preterm Delivery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 terminated, 1 recruiting. 9 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 4, Terminated 4, Recruiting 1
Phase 22Completed 1, Terminated 1

Follow Preterm Delivery: new trials by email Literature Review of Preterm Delivery trials Research Report on Preterm Delivery

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
162mg Aspirin, 81mg Aspirin - Preterm Delivery, Obstetrical Complications
Phase 3RecruitingThe George Washington University Biostatistics Center18002025-07-012026-04-09
Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP)
N-acetylcysteine, Placebo - Preterm Delivery
Phase 2 / Phase 3TerminatedNantes University Hospital392018-11-052022-12-19
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
Arabin Cervical Pessary - Short Cervix, Preterm Delivery
Phase 3TerminatedThe George Washington University Biostatistics Center5442017-02-142026-06-23
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
dydrogesterone, Micronized progesterone - Preterm Delivery
Phase 3CompletedSanpasitthiprasong Hospital2312015-08-012017-10-10
Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)
17-alpha-hydroxy-progesterone caproate, Makena®, Castor Oil (Placebo) - Preterm Delivery
Phase 2 / Phase 3CompletedObstetrix Medical Group1522011-10-012018-06-28
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
17 alpha-hydroxy progesterone caproate, micronized Progesterone, Control - Preterm Delivery, Neonatal Complications
Phase 3CompletedUniversity of Modena and Reggio Emilia2542010-02-012016-09-23
PREGNANT Short Cervix Trial
progesterone, placebo - Preterm Delivery, Short Cervix
Phase 3CompletedJuniper Pharmaceuticals, Inc.4652008-03-012012-03-13
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
17 alpha-hydroxyprogesterone caproate, Placebo Oil - Preterm Delivery, Cervical Length
Phase 3TerminatedThe George Washington University Biostatistics Center6572007-04-012019-07-15
Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
progesterone, placebo - Preterm Delivery, Morbidity
Phase 3Terminatedbegoña Martinez de Tejada3842006-07-012012-06-06

Narrower conditions

Premature Birth (9)  ·  Obstetric Labor, Premature (2)  ·  Perinatal Death (1)  ·  Stillbirth (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (9)  ·  Obstetric Labor Complications (9)  ·  Pregnancy Complications (9)  ·  Urogenital Diseases (9)  ·  Obstetric Labor, Premature (7)  ·  Death (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Fetal Death (1)

Interventions

Progesterone (5)  ·  Utrogestan (3)  ·  17 alpha-Hydroxyprogesterone Caproate (2)  ·  17-alpha-Hydroxyprogesterone (1)  ·  Acetylcysteine (1)  ·  Aspirin (1)  ·  Castor Oil (1)  ·  Dydrogesterone (1)

Sponsors

The George Washington University Biostatistics Center (3)  ·  Juniper Pharmaceuticals, Inc. (1)  ·  Nantes University Hospital (1)  ·  Obstetrix Medical Group (1)  ·  Sanpasitthiprasong Hospital (1)  ·  University of Modena and Reggio Emilia (1)  ·  begoña Martinez de Tejada (1)

Countries

United States (5)  ·  Italy (2)  ·  Argentina (1)  ·  Belarus (1)  ·  Chile (1)  ·  Czechia (1)  ·  France (1)  ·  India (1)  ·  Israel (1)  ·  Russia (1)  ·  South Africa (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  Ukraine (1)

Top investigators

Andrew Combs, MD (1)  ·  Begona Martinez de Tejada, MD, PhD (1)  ·  Cande Ananth, PhD, MPH (1)  ·  Fabio Facchinetti, M.D. (1)  ·  George W. Creasy, MD, FACOG (1)  ·  Matthew Hoffman, MD (1)  ·  Matthew K Hoffman, MD, MPH (1)  ·  Menachem Miodovnik, MD (1)  ·  Monica Longo, MD (1)  ·  Piyawadee Wuttikonsammakit, MD (1)  ·  Rebecca Clifton, Ph.D. (1)  ·  Rebecca G Clifton, PhD (1)  ·  Roberto Romero, MD (1)  ·  Sonia Hassan, MD (1)

Results publications

PMID 21472815, PMID 22206581, PMID 22284156, PMID 23010094, PMID 25209926, PMID 28594783, PMID 37490086, PMID 38576410, PMID 42181103

NIH funding

U24HD036801 (2), 2009 (1), U01HD109332 (1), U10HD021410 (1), U10HD027869 (1), U10HD027915 (1), U10HD027917 (1), U10HD034116 (1), U10HD034136 (1), U10HD034208 (1), U10HD036801 (1), U10HD040485 (1), U10HD040500 (1), U10HD040512 (1), U10HD040544 (1)